Matches in SemOpenAlex for { <https://semopenalex.org/work/W221618059> ?p ?o ?g. }
- W221618059 endingPage "232" @default.
- W221618059 startingPage "223" @default.
- W221618059 abstract "Protein phosphatase 2A (PP2A) is a key negative regulator of phosphatidylinositol 3-kinase/Akt pathway. Previous study showed that, in the liver, the catalytic subunit of PP2A (PP2Ac) is closely associated with insulin resistance syndrome, which is characterized by glucose intolerance and dyslipidemia. Here we studied the role of liver PP2Ac in glucose metabolism and evaluated whether PP2Ac is a suitable therapeutic target for treating insulin resistance syndrome. Liver-specific Ppp2cα knockout mice (Ppp2cαloxp/loxp: Alb) exhibited improved glucose homeostasis compared with littermate controls in both normal and high-fat diet conditions, despite no significant changes in body weight and liver weight under chow diet. Ppp2cαloxp/loxp: Alb mice showed enhanced glycogen deposition, serum triglyceride, cholesterol, low density lipoprotein and high density lipoprotein, activated insulin signaling, decreased expressions of gluconeogenic genes G6P and PEPCK, and lower liver triglyceride. Liver-specific Ppp2cα knockout mice showed enhanced glucose homeostasis and increased insulin sensitivity by activation of insulin signaling through Akt. These findings suggest that inhibition of hepatic Ppp2cα may be a useful strategy for the treatment of insulin resistance syndrome." @default.
- W221618059 created "2016-06-24" @default.
- W221618059 creator A5004853165 @default.
- W221618059 creator A5010093272 @default.
- W221618059 creator A5017218996 @default.
- W221618059 creator A5049256689 @default.
- W221618059 creator A5051558381 @default.
- W221618059 creator A5058223300 @default.
- W221618059 creator A5060696132 @default.
- W221618059 creator A5066820530 @default.
- W221618059 creator A5071316360 @default.
- W221618059 creator A5077566691 @default.
- W221618059 creator A5078802814 @default.
- W221618059 date "2015-02-21" @default.
- W221618059 modified "2023-10-18" @default.
- W221618059 title "Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity" @default.
- W221618059 cites W1802970772 @default.
- W221618059 cites W1983230301 @default.
- W221618059 cites W1984621921 @default.
- W221618059 cites W1988760657 @default.
- W221618059 cites W1997048738 @default.
- W221618059 cites W1998493448 @default.
- W221618059 cites W2003424246 @default.
- W221618059 cites W2003817405 @default.
- W221618059 cites W2014887370 @default.
- W221618059 cites W2015239877 @default.
- W221618059 cites W2016403730 @default.
- W221618059 cites W2019041110 @default.
- W221618059 cites W2022075010 @default.
- W221618059 cites W2023701777 @default.
- W221618059 cites W2028083348 @default.
- W221618059 cites W2038638713 @default.
- W221618059 cites W2049875806 @default.
- W221618059 cites W2053073281 @default.
- W221618059 cites W2056085420 @default.
- W221618059 cites W2058138221 @default.
- W221618059 cites W2060496381 @default.
- W221618059 cites W2061030941 @default.
- W221618059 cites W2061243113 @default.
- W221618059 cites W2062390485 @default.
- W221618059 cites W2074455749 @default.
- W221618059 cites W2079785679 @default.
- W221618059 cites W2096773810 @default.
- W221618059 cites W2106707179 @default.
- W221618059 cites W2109767620 @default.
- W221618059 cites W2111066733 @default.
- W221618059 cites W2115177689 @default.
- W221618059 cites W2119584760 @default.
- W221618059 cites W2121871861 @default.
- W221618059 cites W2130357785 @default.
- W221618059 cites W2132038181 @default.
- W221618059 cites W2137035181 @default.
- W221618059 cites W2142527892 @default.
- W221618059 cites W2171290692 @default.
- W221618059 cites W226119880 @default.
- W221618059 cites W2523875908 @default.
- W221618059 cites W2615637571 @default.
- W221618059 cites W4238567307 @default.
- W221618059 doi "https://doi.org/10.18632/aging.100725" @default.
- W221618059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4429087" @default.
- W221618059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25888638" @default.
- W221618059 hasPublicationYear "2015" @default.
- W221618059 type Work @default.
- W221618059 sameAs 221618059 @default.
- W221618059 citedByCount "18" @default.
- W221618059 countsByYear W2216180592016 @default.
- W221618059 countsByYear W2216180592017 @default.
- W221618059 countsByYear W2216180592018 @default.
- W221618059 countsByYear W2216180592019 @default.
- W221618059 countsByYear W2216180592020 @default.
- W221618059 countsByYear W2216180592022 @default.
- W221618059 countsByYear W2216180592023 @default.
- W221618059 crossrefType "journal-article" @default.
- W221618059 hasAuthorship W221618059A5004853165 @default.
- W221618059 hasAuthorship W221618059A5010093272 @default.
- W221618059 hasAuthorship W221618059A5017218996 @default.
- W221618059 hasAuthorship W221618059A5049256689 @default.
- W221618059 hasAuthorship W221618059A5051558381 @default.
- W221618059 hasAuthorship W221618059A5058223300 @default.
- W221618059 hasAuthorship W221618059A5060696132 @default.
- W221618059 hasAuthorship W221618059A5066820530 @default.
- W221618059 hasAuthorship W221618059A5071316360 @default.
- W221618059 hasAuthorship W221618059A5077566691 @default.
- W221618059 hasAuthorship W221618059A5078802814 @default.
- W221618059 hasBestOaLocation W2216180591 @default.
- W221618059 hasConcept C112446052 @default.
- W221618059 hasConcept C11960822 @default.
- W221618059 hasConcept C126322002 @default.
- W221618059 hasConcept C134018914 @default.
- W221618059 hasConcept C17093226 @default.
- W221618059 hasConcept C192118531 @default.
- W221618059 hasConcept C2777391703 @default.
- W221618059 hasConcept C2777499176 @default.
- W221618059 hasConcept C2778163477 @default.
- W221618059 hasConcept C2778913445 @default.
- W221618059 hasConcept C2779306644 @default.
- W221618059 hasConcept C3018667095 @default.
- W221618059 hasConcept C55493867 @default.